PHOENIX, April 17,
2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES,
"SenesTech" or the "Company"), (www.senestech.com) the rodent
fertility control experts and inventors of the only EPA registered
contraceptive for male and female rats, ContraPest®,
recently concluded participation at New
York's Rodent Roundup.
The New York Pest Management's (NYPMA) Rodent Spring Conference
is a one-of-a-kind event dedicated to providing a day of education
and technology for the pest management industry. With its unique
focus on providing a forum for attendees to learn from each other
about their technology experiences as well as current technologies
used to enhance daily practices within their pest management
businesses, this conference is a prime opportunity to showcase
services and products and promote awareness of the brand to
top-level decision-makers from the pest management industry and
government.
Joel Fruendt, SenesTech's CEO,
attended this conference along with SenesTech's sales team,
highlighting the importance of bringing ContraPest to New York City as Kathleen Corradi, the City's new Director of
Rodent Mitigation, and her team are preparing their new integrated
pest management plan.
"The conference had great participation from the industry and
from the city. We talked to local pest management leaders as well
as representatives from the New York Housing Authority and Parks
Department," said Joel Fruendt,
SenesTech's CEO. "These comments were repeated time and time again
as participants were introduced to ContraPest:"
"This is a great solution to reduce the rat population
without negatively affecting the environment."
"We need
an aggressive pro-active plan to stop reproduction."
"My
customers will love that this provides less risk for their business
and brand."
"This will work great in areas that suffer
from sanitation issues."
"It is so easy to set up and
service."
"I have a few customers that could benefit from
ContraPest today."
"I can't think of anyone in NYC who
could not benefit from the use of ContraPest."
"It is
more affordable than I had heard."
"It is great that you
can now ship directly into NY."
"We are eager to help the new Rat Czar in addressing
New York's rat crisis in an
effective and earth-friendly manner, and these comments from local
pest management professionals certainly should help," added Mr.
Fruendt.
About SenesTech
We are the experts in rat fertility
control. Our passion is to create a healthy environment by better
controlling rat pest populations. We keep an inescapable truth in
mind. Two rats and their descendants can be responsible for the
birth of up to 15,000 pups after a year. We invented ContraPest,
the only U.S. EPA registered contraceptive for male and female
rats. ContraPest fits seamlessly into all integrated pest
management programs, greatly improving the overall goal of
effective rat management. We strive for clean cities, efficient
businesses, and happy households – with a product that was designed
to be effective and sustainable without killing rats. At SenesTech,
we are committed to improving the health of the world by humanely
managing animal populations through fertility control.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor Statement
This press release contains
"forward-looking statements" within the meaning of federal
securities laws, and we intend that such forward-looking statements
be subject to the safe harbor created thereby. Such forward-looking
statements include, among others, our belief that the NYPMA Rodent
Spring Conference is a prime opportunity to showcase services and
products and promote awareness of the brand to top-level
decision-makers from the pest management industry and government;
and our eagerness to help the new Rat Czar in addressing
New York's rat crisis in an
effective and earth-friendly manner, and our belief the comments
from local pest management professionals certainly should help.
Forward-looking statements may describe future expectations, plans,
results or strategies and are often, but not always, made through
the use of words such as "believe," "may," "future," "plan,"
"will," "should," "expect," "anticipate," "eventually," "project,"
"estimate," "continuing," "intend" and similar words or phrases.
You are cautioned that such statements are subject to risks,
uncertainties and other factors that could cause actual results to
differ materially from those reflected by such forward-looking
statements. Such factors include, among others, the impacts and
implications of the COVID-19 pandemic, the successful
commercialization of our products, market acceptance of our
products, regulatory approval and regulation of our products and
other factors and risks identified from time to time in our filings
with the Securities and Exchange Commission, including our Annual
Report on Form 10-K for the fiscal year ended December 31, 2022. All forward-looking statements
contained in this press release speak only as of the date on which
they were made and are based on management's assumptions and
estimates as of such date. Except as required by law, we do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investors: Robert Blum, Joe
Dorame, Joe Diaz, Lytham Partners, LLC,
602-889-9700, senestech@lythampartners.com
Press: Nicole Williams, Chief
Revenue Officer, SenesTech, Inc., 928-779-4143
Company: Tom Chesterman, Chief Financial Officer,
SenesTech, Inc.,
928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-presents-contrapest-at-new-yorks-rodent-roundup-301798513.html
SOURCE SenesTech, Inc.